Table 1 Clinical and biochemical characteristics of study subjects and the differences of factors between patients with high and low SUA levels by gender
General Indexes | Males(n = 656) | Females(n = 431) | ||||
|---|---|---|---|---|---|---|
Low SUA group | High SUA group | P value | Low SUA group | High SUA group | P value | |
Age(yr) | 49.04 ± 11.71 | 42.08 ± 13.02 |  < 0.001* | 52.5 ± 12.35 | 48.6 ± 14.12 | 0.002* |
BMI(kg/m2) | 25.13 ± 3.43 | 28.38 ± 3.92 |  < 0.001* | 25.6 ± 4.55 | 27.04 ± 4.32 | 0.001* |
SBP(mmHg) | 131.81 ± 16.26 | 138.31 ± 16.31 |  < 0.001* | 133.61 ± 18.42 | 138.4 ± 17.99 | 0.007* |
DBP(mmHg) | 82.55 ± 11.09 | 87.55 ± 11.63 |  < 0.001* | 81.28 ± 11.71 | 84.3 ± 11.58 | 0.007* |
ALT (IU/L) | 22.6 (16.9–31) | 34.8 (24.1–60.35) |  < 0.001* | 19 (14–27) | 26.3 (16.85–44.78) | 0.001* |
AST (IU/L) | 21 (17–26) | 26.2 (21.95–43.5) |  < 0.001* | 19.1 (15.62–25.07) | 25.9 (19–34.6) | 0.001* |
γ-GGT (IU/L) | 31 (22–44.1) | 43 (33–73.1) |  < 0.001* | 22.1 (16–38) | 29.8 (20.85–47.18) | 0.005* |
FBG(mmol/L) | 9.61 ± 3.15 | 10.02 ± 3.97 | 0.14 | 9.52 ± 3.63 | 9.97 ± 3.96 | 0.235 |
TC(mmol/L) | 4.9 ± 1.24 | 5.45 ± 1.42 |  < 0.001* | 5.22 ± 1.89 | 5.51 ± 1.61 | 0.027* |
TG(mmol/L) | 1.42 (0.96–2.21) | 2.36 (1.45–4.07) |  < 0.001* | 1.29 (0.93–1.91) | 1.81 (1.21–2.46) |  < 0.001* |
LDL(mmol/L) | 3.11 ± 0.83 | 3.32 ± 0.87 | 0.001* | 3.33 ± 0.84 | 3.40 ± 0.94 | 0.445 |
HDL(mmol/L) | 1.09 ± 0.22 | 1.09 ± 0.32 | 0.87 | 1.26 ± 0.29 | 1.22 ± 0.39 | 0.284 |
BUN(mmol/L) | 5.51 ± 1.47 | 5.49 ± 1.54 | 0.84 | 4.85 ± 1.44 | 5.17 ± 1.98 | 0.053 |
Cr(µmol/L) | 67.07 ± 12.57 | 71.65 ± 18.04 |  < 0.001* | 49.56 ± 11.31 | 55.63 ± 24.95 | 0.001* |
Prevalence rate of MASLD | 55.96% | 88.14% |  < 0.001* | 65.11% | 80.55% |  < 0.001* |